PMDA — authorised 18 June 2019
- Marketing authorisation holder: Nippon Shinyaku Co., Ltd.
- Status: approved
🇯🇵 Defitelio in Japan
PMDA authorised Defitelio on 18 June 2019
Marketing authorisation
Defitelio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Defitelio approved in Japan?
Yes. PMDA authorised it on 18 June 2019.
Who is the marketing authorisation holder for Defitelio in Japan?
Nippon Shinyaku Co., Ltd. holds the Japanese marketing authorisation.